The Oxford Vaccine Group (OVG) conducts studies of new and improved vaccines for children and adults and is based in the Department of Paediatrics at the University of Oxford. The group is led by Professor Andrew J Pollard.
OVG was founded in 1994 by Professor E. Richard Moxon. The multidisciplinary group, led by Professor Pollard since 2001, includes consultants in vaccinology, a Director of Clinical Trials, a Senior Clinical Trials Manager, adult and paediatric clinical research fellows, adult and paediatric research nurses, project managers, statisticians, QA manager, Clinical Trials IT and Development Lead, and an administration team. Our team also includes post doctoral scientists, research assistants and DPhil students and we work together with professionals from a range of specialities such as immunologists, microbiologists, epidemiologists, health communicators, and a sociologist, a community paediatrician, the local Health Protection team and a bioethicist.
OVG is a UKCRC registered clinical trials unit working in collaboration with the Primary Care Trials Unit at the University (registration number: 52). For more information see: http://www.ukcrc-ctu.org.uk/
Conflicts of Interest Statement and Publication Policy
Oxford Vaccine Group follows and works in accordance with the University of Oxford’s Statement of policy and procedure on conflict of interest | Research Support (ox.ac.uk)
Some Oxford Vaccine Group staff work on clinical trials which are conducted by the University of Oxford and sponsored and/or funded by vaccine manufacturers. The sponsors and/or funders of this research are declared in the scientific publications relating to these studies.
Oxford Vaccine Group staff may provide advice to vaccine industry partners to support and enable development and testing of vaccines to improve human health. Such relationships are undertaken following the aforementioned University policy and any potential conflicts of interest are declared in line with the policy of any external agencies or publishers as appropriate.
The results of clinical trials conducted at the Oxford Vaccine Group are published in peer-reviewed journals, and the editorial role of the Oxford Vaccine Group in authorship of these academic papers meets or exceeds the ICMJE guidelines. Oxford Vaccine Group and all its staff act to ensure the independence of the research that is undertaken by the Group on behalf of the University.
Two annual conferences run by the Department of Paediatrics receive unrestricted educational grants from vaccine manufacturers: the annual Immunisation Seminar (for GPs and practice nurses) and “Infection and Immunity in Children” (a course for doctors). Neither organisers nor speakers receive any personal payment for these educational activities.